T-knife

Developer of tumor-specific T cell receptor therapies for the treatment of cancer

placeBerlin, Berlin, Germany calendar_todayFounded 2018 groups8 employees language t-knife.com

Registered entities

Social engagement

Social engagement: 8.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Fidelity Investments, RA Capital Management, Versant Ventures.

Investor typeCountShare
Venture capital538%
Private equity431%
Other / undisclosed431%

Recent activity

25 Jun 2026
Expansion
BioPark Charleroi, a leading Belgian life sciences hub
4 May 2026
Event
BioEquityEurope
23 Mar 2026
Event
SITC Spring Scientific Congress
Coming soon